Fusion event
HBV-SLC2A2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAG| |TTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAAT
End
170738536/171020747 (Hg38)
Nearest miRNA
hsa-let-7g/Upstream/597585; hsa-mir-1224/Downstream/85917;
Upstream sequence
AGATCTTTTAGTTCCAAAACATGTAAGCAAGTCaaggactgaggagctctgatccagacaatttgcacatgttactaatgaaaactctggacttgcagag
Downstream sequence
gtggtgtatgcctgtagtcccagctactcaggaggctgaggtgggaggattgcttgagcccaggaggttgctgctgcagtgagctatgattgcaccacca
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.